CHRISTOPHER N. TA, M.D.
`PROFESSOR
`Byers Eye Institute at Stanford
`Department of Ophthalmology
`2452 Watson Court
`Palo Alto, CA 94303
`
`
`
`
`PROFESSIONAL POSITIONS
`Professor, Stanford University, School of Medicine (2012-present)
`Associate Professor, Stanford University, School of Medicine (2007-2012)
`Assistant Professor, Stanford University, School of Medicine (2000-2006)
`Co-Director of Residency Program, Department of Ophthalmology (2012)
`Director of Residency Program, Department of Ophthalmology (2003-2012)
`Assistant Residency Director, Department of Ophthalmology (1999-2003)
`Acting Assistant Professor, Stanford University, School of Medicine (1999-2000)
`Consultant, Department of Veterans Affairs, Palo Alto Health Care System (2002-2008)
`
`
`
`EDUCATION
`University of Texas, Dallas, Texas, Fellowship in Cornea, External Diseases, and Refractive
`Surgery (1998-1999)
`
`Stanford University Medical Center, Stanford, California, Residency in Ophthalmology
`(1995-1998)
`
`Kaiser Permanente Hospital, Oakland, California, Internship in Internal Medicine (1994-1995)
`
`University of Minnesota Medical School, Minneapolis, Minnesota (1990-1994)
`
`University of Minnesota, College of Liberal Arts, Minneapolis, Minnesota (1986-1990)
`
`
`
`BOARD EXAM CERTIFICATION
`Recertified by American Board of Ophthalmology – January 2011 to December 2020
`
`
`
`PEER-REVIEWED PUBLICATIONS
`
`1. Tan XW, Hartman L, Tan KP, Poh R, Myung D, Zheng LL, Waters D, Noolandi J,
`Beuerman RW, Frank CW, Ta CN, Tan DTH, Mehta JS. “In vivo biocompatibility of
`two PEG/PAA interpenetratingpolymer networks as corneal inlays following deep
`stromal pocket implantation.” Journal of Material Science: Materials in medicine. 2013.
`
`
`1
`
`
`
`
`
`APOTEX 1008, pg. 1
`
`

`
`2. Ko MS and Ta CN. “Should we be concerned about antibiotic resistance when using
`intravitreal injections. ” Expert Reviews in Ophthalmology. 2012;7(5) :393-395.
`
`3. Charalel RA, Engberg K, Noolandi J, Cochran JR, Frank C, Ta CN. “Diffusion of
`Protein Through the Human Cornea.” Ophthalmic Research. 2012;48(1):50-55.
`
`4. Nentwich MM, Rajab M, Ta CN, He L, Grueterich M, Haritoglou C, Gandorfer A,
`Kampik A, Mino De Kaspar H. "Application of 10% povidone iodine reduces
`conjunctival bacterial contamination rate in patients undergoing cataract surgery. ” Eur J
`Ophthalmol. 2012. July, 22 (4) 541-6.
`
`
`5. Yu C and Ta CN. "Prevention of post cataract endophthalmitis: evidence based
`medicine. ” Current Opinion in Ophthalmology. 2012 Jan;(1):19-25.
`
`6. Waters D, Engberg K, Parke-Houben R, Ta CN, Jackson A, Toney M, Frank C.
`"Structure and Mechanism of Strength Enhancement in Interpenetrating Polymer
`Network Hydrogels. ” Macromolecules. 2011; 44(14):5776-5787.
`
`7. Hartmann L, Watanabe K, Zheng LL, Kim C-Y, Beck SE, Huie P, Noolandi J, Cochran
`JR, Ta CN, Frank CW. “Towards the development of an artificial cornea: improved
`stability of interpenetrating polymer networks.” Journal of Biomedical Materials
`Research: Part B Applied Biomaterials. 2011 July; 98B: 8–17.
`
`8. Ta CN and Sun Y. “Corneal decompensation in Axenfeld-Rieger syndrome and
`associated histopathological findings.” Minerva Oftalmologica. 2011. March; 53(1):
`29-30.
`
`9. Sáles CS, Johnston LJ, Ta CN. “Long-term clinical course of dry eye in patients with
`chronic graft-versus-host disease referred for eye examination.” Cornea. 2011 Feb;
`30(2):143-149.
`
`10. Moss JM, Sanislo SR, Ta CN. “Antibiotic susceptibility patterns of ocular bacterial flora
`in patients undergoing intravitreal injections.” Ophthalmology. 2010 Nov;117(11):2141-
`5.
`
`11. Waters D, Engberg K, Parke-Houben R, Hartmann L, Ta C, Toney M, Frank C.
`“Morphology of photopolymerized end-linked poly (ethylene glycol) hydrogels by small
`angle x-ray scattering.” Journal of Macromolecules. 2010 July; 43, 6861-6870.
`
`12. He L, Ta CN, Miño de Kaspar H. “One-day application of topical moxifloxacin 0.5% to
`select for fluoroquinolone-resistant coagulase-negative Staphylococcus.” J Cataract
`Refract Surg. 2009 Oct;35(10):1715-8.
`
`13. Miño De Kaspar H, Ta CN, Froehlich SJ, Schaller UC, Engelbert M, Klauss V, Kampik
`A. “Prospective study of risk factors for conjunctival bacterial contamination in patients
`undergoing intraocular surgery.” Eur J Ophthalmol. 2009 Sep-Oct;19(5):717-22.
`
`2
`
`
`
`
`
`
`
`
`
`
`
`APOTEX 1008, pg. 2
`
`

`
`14. Moss JM, Sanislo SR, Ta CN. “A prospective randomized evaluation of topical
`gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.”
`Ophthalmology. 2009 Aug;116(8):1498-501.
`
`15. He L, Ta CN, Hu N, Sinnar S, Miño de Kaspar H. “Prospective randomized comparison
`of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative
`conjunctival bacteria.” J Ocul Pharmacol Ther. 2009 Aug; 25(4):373-8.
`
`16. Yactayo-Miranda Y, Ta CN, He L, Kreutzer TC, Nentwich MM, Kampik A, Mino de
`Kaspar H. “A prospective study determining the efficacy of topical 0.5% levofloxacin on
`bacterial flora of patients with chronic blepharoconjunctivitis.” Graefes Arch Clin Exp
`Ophthalmol. 2009 Jul;24(7):993-8.
`
`17. Ta CN, He L, Mino de Kaspar H. “In vitro antibiotic susceptility of preoperative normal
`conjunctival bacteria. ” Eye. 2009 Mar; 23(3):559-60.
`
`18. Moss JM, Nguyen D, Liu YI, Singh K, Montague A, Egbert PR, de Kaspar HM, Ta CN.
`“Comparison of one-day vs one-hour application of topical gatifloxacin in eliminating
`conjunctival bacterial flora.” Ophthalmology. 2008 Nov; (115):2013-2016.
`
`19. Ta CN, Chan I, Dhatt HS, Paterno J, Fisher E, Singh K, Montague A, Egbert P,
`Cockerham G, de Kaspar HM. “Prospective comparison of topical moxifloxacin in
`eliminating conjunctival bacterial flora following a one-day or one-hour application.”
`Journal of Ocular Pharmacology and Therapeutics. 2008 Aug; 24(4): 427-31.
`
`20. DeCaro JJ, Ta CN, Ho HV, Cabael L, Hu N, Sanislo SR, Blumenkranz MS, Moshfeghi
`DM, Jack R, de Kaspar HM. “Bacterial contamination of ocular surface and needles in
`patients undergoing intravitreal injections.” Retina. 2008 Jun; 28(6):877-883.
`
`21. Myung D, Farooqui N, Zheng LL, Koh W, Gupta S, Bakri A, Noolandi J, Cochran JR,
`Frank CW, Ta CN. “Bioactive interpenetrating polymer networks hydrogels that support
`corneal epithelial wound healing.” Journal of Biomedical Materials Research. 2008
`May; 15. 90A(1):70-81.
`
`22. Myung D, Wiseman M, Waters D, Duhamel P-E, Noolandi J, Ta C, Frank CW.
`“Progress in the development of interpenetrating polymer network hydrogels.” Polymers
`for Advanced Technologies.” 2008 Apr; 19(6): 647-657.
`
`23. Myung D, Duhamel P-E, Cochran JR, Noolandi J, Ta CN, Frank CW. “Development of
`hydrogel-based keratoprostheses: a materials perspective.” Biotechnol Prog. 2008 May-
`Jun; 24(3): 735-741.
`
`24. De Kaspar HM, Ta CN, Engelbert M, Mette M, Thiel M, Kampik A. “Effects of
`intravitreal corticosteroid in the treatment of staphylococcus aureus-induced experimental
`endophthalmiitis.” J Retina & Vitreous Diseases. 2008 Feb; 28(2):326-332.
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`APOTEX 1008, pg. 3
`
`

`
`25. Ta CN, Egbert PR, Singh K, De Kaspar HM. “Prospective comparative evaluation of
`povidone-iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for
`ophthalmic surgery.” J. Cataract and Refract Surg. 2008 Jan; 34(1): 171-172.
`
`26. Myung D, Farooqui N, Waters D, Schaber S, Koh W, Carrasco M, Noolandi N, Frank
`CW, Ta CN. “Glucose-permeable interpenetrating polymer network hydrogels for
`corneal implant applications: a pilot study.” Current Eye Research. 2008 Jan;33(1):29-
`42.
`
`27. Miño De Kaspar H, Kreutzer TC, Aguirre-Romo I, Ta CN, Dudichum J, Bayrhof M,
`Klauss V, Kampik A. “A prospective randomized study to determine the efficacy of
`preoperative topical levofloxacin in reducing conjunctival bacterial flora.” Am J
`Ophthalmol. 2008 Jan; 145(1): 136-142e2.
`
`28. Myung D, Koh WG, Ko J, Hu Y, Carrasco M, Noolandi J, Ta CN, and Frank CW.
`“Biomimetic strain hardening in interpenetrating polymer network hydrogels.” Polymer.
`2007, 48(18), 5376-5387.
`
`29. Ta CN, Lin RC, Singh G, Miño De Kaspar H. ” Prospective study demonstrating
`efficacy of combined preoperative three-day application of antibiotics and povidone-
`iodine irrigation.” Annals of Ophth. 2007 Oct; 39(4): 313-317.
`
`30. Ta CN, Sinnar S, He L, Myung D, Mino De Kaspar H. “Prospective randomized
`comparison of 1-day versus 3-day application of topical levofloxacin in eliminating
`conjunctival flora.” Eur J Ophthalmol. 2007 Sep-Oct; 17(5):689-95.
`
`31. Farooqui N, Myung D, Koh K, Masek M, Dalal R, Carrasco MR, Noolandi N, Frank
`CW, Ta CN. "Histological processing of pH-sensitive H93ydrogels used in corneal
`implant applications." J. Histotechnology. 2007 Sep; 30(3): 157-163.
`
`32. Sun Y, Jain A, Ta CN. “Aspergillus fumigatus keratitis following laser in situ
`keratomileusis.” J Cataract Refract Surg. 2007 Oct; 33(10):1806-7.
`
`33. Ta CN. “Topical antibiotic prophylaxis in intraocular injections.” Arch Ophthalmol.
`2007 Jul; 125(7):972-4.
`
`34. Myung D, Koh W, Bakri A, Zhang F, Marshall A, Ko J, Noolandi J, Carrasco M,
`Cochran JR, Frank CW, Ta CN. “Design and fabrication of an artificial cornea based on
`a photolithographically patterned hydrogel construct.” Biomed MicroDevices. 2007 Dec;
`9:911-922.
`
`35. Koss MJ, Eder M, Blumenkranz MS, Klauss V, Ta CN, de Kaspar HM. "[The
`effectiveness of the new fluoroquinolones against the normal bacterial flora of the
`conjunctiva.]" Ophthalmologe. 2007; 104: 21-7.
`
`4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`APOTEX 1008, pg. 4
`
`

`
`36. Ou JI, Ta CN. "Endophthalmitis prophylaxis." Ophthalmol Clin North Am. 2006 Dec;
`19(4): 449-56.
`
`37. Ta CN, He L, Nguyen E, De Kaspar HM. “Prospective randomized study determining
`whether a 3-day application of ofloxacin results in the selection of fluoroquinolone-
`resistant coagulase-negative staphylococcus.” Eur J Ophthalmol. 2006 May-
`Jun;16(3):359-64.
`
`38. Myung D, Derr K, Huie P, Noolandi J, Ta KP, Ta CN. “Glucose permeability of human,
`bovine, and porcine corneas in vitro.” Ophthalmic Res. 2006 Jan; 38(3):158-163.
`
`39. Sonego-Krone S, Sanchez-Di Martino D, Ayala-Lugo R, Torres-Alvariza G, Ta CN,
`Barbosa L, de Kaspar HM. "Clinical results of topical fluconazole for the treatment of
`filamentous fungal keratitis." Graefes Arch Clin Exp Ophthalmol. 2006; 244(7):782-7.
`
`40. Eder M, Fariña N, Sanabria RR, Ta CN, Koss M, Samudio M, Cuevas C, Gines A,
`Simancas M, Klauss V, Miño de Kaspar H. “Normal ocular flora in newborns delivered
`in two hospital centers in Argentina and Paraguay." Graefes Arch Clin Exp Ophthalmol.
`2005; 243(11):1098-107.
`
`41. de Kaspar HM, Kreutzer TC, Ta CN, Kampik A. “Use of rapid antibiotic susceptibility
`testing in bacterial endophthalmitis.” Retina. 2005 Apr-May;25(3):386-7.
`
`42. Miño de Kaspar H, Koss MJ, He L, Blumenkranz MS, Ta CN. "Antibiotic susceptibility
`of preoperative normal conjunctival bacteria." Am J Ophthalmol. 2005 April; 139(4):
`730-3.
`
`43. Mino de Kaspar H, Chang RT, Singh K, Egbert PR, Blumenkranz MS, Ta CN.
`“Prospective randomized comparison of 2 different methods of 5% povidone-iodine
`applications for anterior segment intraocular surgery.” Arch Ophthalmol. 2005 Feb;
`123(2):161-5.
`
`44. de Kaspar HM, Kreidl KO, Singh K, Ta CN. “Comparison of preoperative conjunctival
`bacterial flora in patients undergoing glaucoma or cataract surgery. J Glaucoma. 2004
`Dec; 13(6):507-9.
`
`45. Ta CN. “Minimizing the risk of endophthalmitis following intravitreous injections.”
`Retina. 2004 Oct; 24(5):699-705.
`
`46. Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D'Amico DJ, Flynn HW Jr,
`Grillone LR, Hutcherson S, Liebmann JM, O'Brien TP, Scott IU, Spaide RF, Ta CN,
`Trese MT. “Evolving guidelines for intravitreous injections.” Retina. 2004 Oct; 24(5
`Suppl):S3-19.
`
`47. Mino De Kaspar H, Chang RT, Shriver EM, Singh K, Egbert PR, Blumenkranz MS, Ta
`CN. “Three-day application of topical ofloxacin reduces the contamination rate of
`
`5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`APOTEX 1008, pg. 5
`
`

`
`microsurgical knives in cataract surgery: A prospective randomized study.”
`Ophthalmology. 2004 Jul; 111(7):1352-5.
`
`48. Ta CN, Egbert PR, Singh K, Blumenkranz MS, Mino De Kaspar H. “The challenge of
`determining aqueous contamination rate in anterior segment intraocular surgery.”
`American Journal of Ophthalmology. 2004 Apr; 137(4):662-7.
`
`49. Engelbert M, Mino De Kaspar H, Thiel M, Grasbon T, Ta CN, Schulze-Schwering M,
`Klauss V, Kampik A. “Intravitreal vancomycin and amikacin versus intravenous
`imipenem in the treatment of experimental staphylococcus aureus endophthalmitis.”
`Graefes Arch Clin Exp Ophthalmol. 2004 Apr; 242(4):313-20.
`
`50. Laspina F, Samudio M, Cibils D, Ta CN, Farina N, Sanabria R, Klauss V, Mino De
`Kaspar H. “Epidemiological characteristics of microbiological results on patients with
`infectious corneal ulcers: a 13-year survey in Paraguay.” Graefes Arch Clin Exp
`Ophthalmol . 2004 Mar; 242(3):204-9.
`
`51. Engelbert M, Mino De Kaspar H, Mette M, Thiel M, Ta CN, Grasbon T, Schulze-
`Schwering M, Klauss V, Kampik A. “Intravenous treatment of experimental
`staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime
`and amikacin.” Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):1029-36.
`
`52. Mino De Kaspar H, Shriver EM, Nguyen EV, Egbert PR, Singh K, Blumenkranz MS, Ta
`CN. “Risk factors for antibiotic-resistant conjunctival bacterial flora in patients
`undergoing intraocular surgery.” Graefes Arch Clin Exp Ophthalmol. 2003
`Sep;241(9):730-3.
`
`53. Ta CN, Egbert PR, Singh K, Blumenkranz MS, Mino De Kaspar H. “Preoperative
`ofloxacin: author reply.” Ophthalmology. 2003; 110(12):2431-2.
`
`54. Ta CN, Chang RT, Singh K, Egbert PR, Shriver EM, Blumenkranz MS, Mino de Kaspar
`H. “Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients
`undergoing anterior segment surgery.” Ophthalmology. 2003 Oct; 110(10):1946-51.
`
`55. Ta CN, Shine WE, McCulley JP, Pandya A, Trattler W, Norbury JW. “Effects of
`minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis.”
`Cornea. 2003; 22(6):545-8.
`
`56. Braun MM, Wong IG, Ta CN. “Nodular scleritis in a patient with pyoderma
`gangrenosum.” Arch Ophthalmol. 2002;120(12):1763-5.
`
`57. Shaikh S, Ta CN. “Evaluation and treatment of herpes zoster ophthalmicus.” Am Fam
`Physician. 2002;66 (9):1723-30.
`
`58. Ta CN, Egbert PR, Singh K, Shriver EM, Blumenkranz MS, Miño de Kaspar H.
`“Prospective randomized comparison of three day versus one hour preoperative ofloxacin
`
`6
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`APOTEX 1008, pg. 6
`
`

`
`prophylaxis for cataract surgery.” Ophthalmology. 2002; 109(11):2036-40; discussion
`2040-1.
`
`59. Giaconi J, Pham R, Ta CN. “Bilateral mycobacteria abscessus keratitis after laser in situ
`keratomileusis.” J of Cataract and Refract Surg. 2002; 28(5):887-90.
`
`60. Miño de Kaspar H, Molnar A, Neubauer AS, Hoepfner AS, Ta CN, Grasbon T,
`Engelbert M, Thiel M, Klauss V, Kampik A. “Rapid direct antibiotic susceptibility
`testing in endophthalmitis.” Ophthalmology. 2002; 109(4):687-93.
`
`61. Mino de Kaspar H, Engelbert M, Thiel M, Grasbon T, Ta CN, Klauss V, Kampik A.
`“Intravenous imipenem prophylaxis in experimental endophthalmitis.” Graefes Arch
`Clin Exp Ophthalmol. 2002; 240(7):557-64.
`
`62. Mino De Kaspar H, Hoepfner AS, Engelbert M, Thiel M, Ta CN, Mette M, Schulze-
`Schwering M, Grasbon T, Sesma-Vea B, Casas JM, Iturralde-Goni R, Klauss V, Kampik
`A. “Antibiotic resistance pattern and visual outcome in experimentally-induced
`Staphylococcus epidermidis endophthalmitis in a rabbit model.” Ophthalmology. 2001;
`108(3):470-8.
`
`63. Shaikh S, Ta C, Basham AA, Mansour S. “Leber hereditary optic neuropathy associated
`with antiretroviral therapy for human immunodeficiency virus infection.” Am J
`Ophthalmol. 2001; 131(1):143-5.
`
`64. Ta CN, Bowman RW. “Hyphema caused by a metallic intraocular foreign body during
`magnetic resonance imaging.” Am J Ophthalmol. 2000; 129(4):533-4.
`
`65. Pazour GJ, Ta CN, Das A. “Constitutive mutations of agrobacterium tumafaciens
`transcriptional activator Vir G.” J Bacteriol. 1992; 174:4169-74.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`66. Pazour GJ, Ta CN, Das A. “Mutants of agrobacterium tumafaciens with elevated Vir
`gene expression.” Proc Natl Acad Sci. 1991; 88:6941-5.
`
`
`
`NON-PEER-REVIEW ARTICLES
`
`Ta CN. “The Changing Epidemiology of Ocular Shingles.” Topics in Ocular Antiinfectives
`February 2011.
`Ta CN. “Pharmacokinetics / Pharmacodynamics of Topical Ocular Antibiotics.” Topics in
`Ocular Antiinfectives 2010.
`Ta CN. “Danger of Oversimplification.” EyeNet March 2010.
`Ta CN. “What are the Best Topical Antibiotics?” Cataract & Refractive Surgery Today 2007.
`Ta CN. “Improving OR Bacteria Control.” Review of Ophthalmology May 2005.
`Ta CN. “Should We Worry about Injection Infection?” Review of Ophthalmology Mar 2004.
`Ta CN. “Herpes Simplex Epithelial Keratitis.” MDvista Journal of Medicine 2000.
`Ta CN. “Herpes Simplex Stromal Keratitis.” MDvista Journal of Medicine 2000.
`
`
`
`7
`
`APOTEX 1008, pg. 7
`
`

`
`
`
`BOOK CHAPTERS
`
`
`1. Paulus YM and Ta CN. “Ocular Antibiotics.” Copeland and Afshari Principles and
`Practice of Cornea, Jaypee Brothers 2012. Ch. 20 pp
`
`2. Ta CN. “What are the Best Topical Agents for Prophylaxis?” Cataract Surgery Today,
`Bryn Mawr Communications LLC, 2009. Ch. 96 pp223-6.
`
`3. Friedman, NJ and Kaiser PK. “The Massachusetts Eye and Ear Infirmary Illustrated
`Manual of Ophthalmology.” Saunders Elsevier, 3rd Edition 2009 photographs credited
`3-15, 3-26, 3-27, 4-10, 4-22, 4-23, 4-24, 5-1, 5-23, 5-54, 5-59, 5-77, 7-38, and 12-2.
`
`4. Ta CN, Bowman RW, McCulley JP. “Ocular Bacteriology.” In Albert & Jacobiec,
`Saunders-Elsevier, 2008. Canada . Vol. 1(11): pp101-116.
`
`5. Ou J, Ta CN. “Keratoconus and Pellucid Marginal Degeneration: Optics, Etiology and
`Clinical Presentations of the Irregular Cornea.” In Irregular Astigmatism ¨Diagnosis and
`Treatment. Eds: Ming Wang. Slack Publishers, Inc. 2008. Ch 6 pp53-59.
`
`6. Ou J, Ta CN. “Endophthalmitis Prophylaxis.” Ed. Mark H. Blecher, M.D. In
`Ophthalmology Clinics of North America: Cataract Surgery in the New Millennium;
`Elsevier-Saunders, Philadelphia. December 2006. Vol. 19(4): pp 449-456.
`
`7. Ta CN. “Fibrin Deposition on Intraocular Lenses.” In Ophthalmology Review: A Case
`Study Approach. Eds: Kuldev Singh, William E., M.D. Smiddy, Andrew G. Lee.
`Thieme Medical Publishers, Inc. Dec 15, 2001: pp 61-3.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ABSTRACT PUBLICATIONS
`
`Ko M, Johnston L, Ta CN. Risk Factors for the Development of Ocular Graft Versus Host
`Disease after Hematopoietic Cell Transplantation. The Association for Research in Vision and
`Ophthalmology. Fort Lauderdale, FL. May 6, 2012. Poster A215.
`
`Sales CS, Ta CN. Long-Term Follow-Up of Patients With Dry Eye Associated With Chronic
`Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation. American Academy
`of Ophthalmology Annual Meeting. Fort Lauderdale, FL. May 4, 2010. Poster 1060.
`
`Zheng L, Huie P, Vanchinathan V, Noolandi J, Dalal R, Hartmann L, Cochran JR, Frank CW, Ta
`CN. Long-Term Biocompatibility of PEG/PAA Hydrogel by Intrastromal Implantation in Rabbit
`
`
`
`8
`
`APOTEX 1008, pg. 8
`
`

`
`Cornea. American Academy of Ophthalmology Annual Meeting. Fort Lauderdale, FL. May 2,
`2010. Poster 965.
`
`Parke-Houben R, Hu Y, Zheng L, Ta CN, Cochran JR, Frank CW. Development of Porous
`Interpenetrating Network Hydrogels for High Strength Artificial Cornea Periphery American
`Academy of Ophthalmology Annual Meeting. Fort Lauderdale, FL. May 2, 2010. Poster 976.
`
`Moss JM, Sanislo SR, Ta CN. Antibiotic Susceptibility Patterns of Ocular Bacterial Flora in
`Patients Undergoing Intravitreal (IVT) Injections. American Academy of Ophthalmology
`Annual Meeting. San Francisco, CA. October 26, 2009. Poster 376.
`
`Zheng L, Beck SE, Hartmann L, Schlinker AC, Noolandi J, Frank CW, Ta CN, Cochran JR.
`Surface-Modifying a Hydrogel Designed for Artificial Cornea With Extracellular Matrix
`Proteins to Promote Epithelialization. The Association for Research in Vision and
`Ophthalmology. Fort Lauderdale, FL, May 4, 2009. Poster 225.
`
`
`Hartmann L, Beck SE, Zheng L-L, Kim C-Y, Huie P, Noolandi J, Cochran J, Ta CN, Frank CW.
`Designing an Artificial Cornea - Longterm Stability and in vivo Testing. The Association for
`Research in Vision and Ophthalmology. Fort Lauderdale, FL, May 4, 2009. Poster 225.
`
`Charalel RA, Engberg K, Noolandi J, Cochran J, Frank C, Ta CN. Diffusion of Protein Through
`the Human Cornea. The Association for Research in Vision and Ophthalmology. Fort
`Lauderdale, FL, May 4, 2009. Poster 254.
`
`Vanchinathan V, Huie P, Noolandi J, Waters DJ, Hartmann L, Frank CW, Cochran JR,
`Blumenkranz MS, Ta CN. Corneal Inlay of Biomimetic Interpenetrating Network Hydrogel in
`Rabbit. The Association for Research in Vision and Ophthalmology. Fort Lauderdale, FL, May
`4, 2009. Poster 282.
`
`Myung D, Beck S, Zheng L, Waters D, Noolandi J, Frank CW, Cochran JR, Ta CN. “Sequential
`Coupling of Epidermal Growth Factor and Collagen to Polymers to Promote Corneal
`Epithelialization in vitro.” The Association for Research in Vision and Ophthalmology. Fort
`Lauderdale, FL, May 1, 2008. Poster 5729.
`
`Waters D, Myung D, Huie P , Noolandi J, Cochran JR, Ta CN, Frank CW. “Oxygen and
`Oligosaccharide Diffusion in Interpenetrating Network Hydrogels for Replacement of Corneal
`Tissue.” The Association for Research in Vision and Ophthalmology. Fort Lauderdale, FL, May
`1, 2008. Poster 5720.
`
`Zheng L, Blaha CM, Beck SE, Myung D, Cochran JR, Ta CN. “Morphology and Phenotype
`Comparison of Primary Rabbit Epithelial Cell Cultures in Serum-Fortified and Serum-Free
`Media.” The Association for Research in Vision and Ophthalmology. Fort Lauderdale, FL, Apr
`29, 2008. Poster 3368.
`
`
`
`
`9
`
`APOTEX 1008, pg. 9
`
`

`
`Chan A, Myung D, Waters DJ, Frank CW, Ta CN. “Drug Release of Vancomycin and
`Tobramycin From a Soft Contact Lens Based System.” The Association for Research in Vision
`and Ophthalmology. Fort Lauderdale, FL, Apr 29, 2008. Poster 3189.
`
`Moss JM, Cabael L, Sanislo SR, Ta CN. “Efficacy of 3-Day Topical Gatifloxacin in Reducing
`Injection Site Flora in Patients undergoing Intravitreal injections.” The Association for Research
`in Vision and Ophthalmology. Fort Lauderdale, FL, April 27, 2008. Poster 963.
`
`Moss JM, Montague AA, Egbert PR, Singh K, Mino de Kaspar H, Ta CN. “Comparion of One-
`Day and One-Hour Preoperative Application of Topical Gatifloxacin in Eliminating Conjunctival
`Bacterial Flora.” American Academy of Ophthalmology Annual Meeting. New Orleans, LA.
`November 12. 2007.
`
`Myung D, Cochran JR, Noolandi J, Ta CN, Frank CW. “Engineering Epidermal Growth Factor
`for Artificial Cornea Applications” Biomedical Engineering Society. Los Angeles, CA, Sep 28
`2007.
`
`Myung D, Cochran JR, Noolandi J, Ta CN, Frank CW. “A Novel, Biomimetic Hydrogel
`Construct To Repair The Cornea: Molecular Design and Biological response.” ACS National
`Meeting, Boston, MA, August 19-23, 2007.
`
`Moss JM, Liu YI, Nguyen D, Montague A, Egbert P, Singh K, Mino de Kaspar H, Ta CN.
`“Prospective Comparison of 1-Day vs 1-Hour Pre-Operative Topical Gatifloxacin Prophylaxis
`for Intraocular Surgeries.” The Association for Research in Vision and Ophthalmology. Fort
`Lauderdale, FL, May 9, 2007.
`
`Ta CN, Sahm DF. “Antimicrobial Susceptibility Patterns in MRSA vs MSSA Eye Infection:
`Results from Ocular TRUST.” The Association for Research in Vision and Ophthalmology.
`Fort Lauderdale, FL, May 8, 2007.
`
`Zheng L, Myung D, Bakri A, Noolandi J, Cochran J, Frank C, Ta CN. “Biological Activity of
`Collagen Type I to Surfaced-Modified Hydrogels.” The Association for Research in Vision and
`Ophthalmology. Fort Lauderdale, FL, May 7, 2007.
`
`Myung D, .Zheng L, Bakri A, Marshall A, Duhamel PE, Carrasco M, Noolandi J, Cochran C,
`FranK CW, Ta CN. “Development of a Novel Keratoprosthesis Based on Photolithographically
`Patterned, Biomimetic Hydrogels.” The Association for Research in Vision and Ophthalmology.
`Fort Lauderdale, FL, May 7, 2007.
`
`Liu YI, Moss JM, Nguyen D, Mino de Kaspar H, Ta CN. “Antibiotic Resistance Patterns of
`Ocular Bacterial Flora.” The Association for Research in Vision and Ophthalmology. Fort
`Lauderdale, FL, May 6, 2007.
`
`Ta CN, Shahinian L. “Soft Lens Immune Keratitis (SLIK): A Clinical Condition Treatable with
`Topical Cyclosporine.” Asia Journal of Ophthalmology. 2007; 9(1):p215.
`
`
`
`
`10
`
`APOTEX 1008, pg. 10
`
`

`
`Golnik KC, Lee, AG. “The On-Call Assessment Tool: Inter-rater Reliability Determination.”
`American Academy of Ophthalmology Annual Meeting. Las Vegas, NV. November 13. 2006.
`
`Bakri A, Farooqui N, Myung D, Koh WG, Noolandi J, Carrasco M, Frank C, Ta CN. “In Vivo
`Biocompatibility of Poly(Ethylene Glycol)/Poly(Acrylic Acid) Double Network Corneal Inlays.”
`American Academy of Ophthalmology Annual Meeting. Las Vegas, NV. November 13. 2006.
`
`Chan IHY, Dhatt HS, Paterno JM, Fisher E, Montague AA, Egbert PR, Singh K, Mino de Kaspar
`H, Cockerham GC, Ta CN. “Prospective Comparison of One-Day vs. One-Hour Preoperative
`Moxifloxacin Prophylaxis for Intraocular Surgeries.” American Academy of Ophthalmology
`Annual Meeting. Las Vegas, NV. November 12. 2006.
`
`Ta CN, Sahm DF, Ingerman A. “ Levofloxacin Susceptibility in Multi-Drug-Resistant S.
`pneumoniae Isolates from the Nationwide TRUST Surveillance Study, 2000-2004.” The
`Association for Research in Vision and Ophthalmology. Fort Lauderdale, FL, May 3, 2006.
`
`Chan I, Dhatt H, Paterno J, Fisher E, Montague A, Egbert P, Singh K, Mino de Kaspar H,
`Cockerham G, Ta CN.. “Prospective Comparison of 1-Day vs 1-Hour Pre-Operative
`Moxifloxacin Prophylaxis for Intraocular Surgeries.” The Association for Research in Vision
`and Ophthalmology. Fort Lauderdale, May 2006.
`
`Bakri A, Farooqui N, Myung D, Koh WG, Noolandi J, Carrasco M, C.Frank, Ta CN.
`“Biocompatibility of a Hydrogel Corneal Inlay in vivo.” The Association for Research in Vision
`and Ophthalmology. Fort Lauderdale, May 2006.
`
`Myung D, Koh W, Farooqui N, Ko J, Noolandi J, Carrasco M, Frank CW, Ta CN.
`“Development of a Hydrogel Corneal Onlay: Molecular Design and Biological Response.” The
`Association for Research in Vision and Ophthalmology. Fort Lauderdale, May 2006.
`
`Mino De Kaspar H, Aguirre-Romo I, Kreutzer T, Ta CN, Dudichum J, Bayrhof M, Hartman K,
`Kampik A. “Comparison of Levofloxacin and Iodine Prophylaxis versus Iodine for Intraocular
`Surgery.” 4th International Conference on Ocular Infections. Sapporo, Hokkaido, Japan,
`October 1-4, 2005.
`
`Mino De Kaspar H, Aguirre-Romo I, Kreutzer T, Ta CN, Dudichum J, Bayrhof M, Hartman K,
`Kampik A. “Comparison of Levofloxacin and Iodine Prophylaxis versus Iodine Alone for
`Intraocular Surgery: A Prospective Randomized Study.” European Society of Cataract and
`Refractive Surgery Conference. Electronic Presentation (www.escrs.org/events/05Lisbon),
`Lisbon, Portugal, September 10-14, 2005.
`
`Farooqui N, Myung D, Masek M, Dalal R, Koh W, Gupta S, Noolandi J, Frank C, Ta CN.
`“Histological Evaluation of Poly (Ehtylene Glycol) Poly (Acrylic Acid)(PEG-PAA) Double
`Network hydrogel Corneal Implant.” The Association for Research in Vision and
`Ophthalmology. CD-ROM, Fort Lauderdale, May 2005.
`
`
`
`
`11
`
`APOTEX 1008, pg. 11
`
`

`
`Noolandi J, Myung D, Derr K, Huie P, Ta C. “Glucose Permeability of Human, Bovine, and
`Porcine Corneas In Vitro.” The Association for Research in Vision and Ophthalmology. CD-
`ROM, Fort Lauderdale, May 2005.
`
`Ho H-KV, Hu N, Sanislo SR, Mino de Kaspar H, Ta CN. “Prevalence of Bacterial
`Contamination of needles Following Intravitreal Injection of Triamcinolone Acetonide.” The
`Association for Research in Vision and Ophthalmology. CD-ROM, Fort Lauderdale, May 2005.
`
`Hu, N, Espinosa L, Sinnar S, Egbert PR, Singh K, Ho H-KV, Ta CN. “Topical 0.5%
`Moxifloxacin Significantly Reduces Pre-Operative Conjunctival Bacteria.” The Association for
`Research in Vision and Ophthalmology. CD-ROM, Fort Lauderdale, May 2005.
`
`Koh WG, Myung D, Ko J, Noolandi J, Frank CW, Ta CN. “Synthesis and Surface Modification
`of Double Network Hydrogel From Poly (Ethylene Glycol) and Poly (Acrylic Acid).” The
`Association for Research in Vision and Ophthalmology. CD-ROM, Fort Lauderdale, May 2005.
`
`Myung D, Koh W, Ko J, Noolandi J, Carrasco M, Smith A, Frank C, Ta CN. “Characterization
`of Poly (Ehtylene Glycol) Poly (Acrylic Acid) (PEG-PAA) Double Networks Designed for
`Corneal Implant Applications.” The Association for Research in Vision and Ophthalmology.
`CD-ROM, Fort Lauderdale, May 2005.
`
`He L, Ta CN, Sinnar S, Myung D, Mino de Kaspar H. “One-Day Application of 0.5% Topical
`Levofloxacin Has Similar Efficacy as a Three-Day Regimen in Eliminnating Bacgteria From the
`Ocular Surface.” The Association for Research in Vision and Ophthalmology. CD-ROM, Fort
`Lauderdale, May 2005.
`
`De Kaspar HM, Singh G, Egbert PR, Haw WW, Nguyen EV, Singh K, Blumenkranz MS and Ta
`CN. „Ten-Fold Reduction of Conjunctival Bacterial Contamination Rate Using a Combined 3-
`Day Application of Topical Ofloxacin and Iodine Irrigation in Patients Undergoing Anterior
`Segment Intraocular Surgery.” Invest Ophthalmol Vis Sci 2003; E-Abstract 1457.
`
`Miño de Kaspar H, Chang RT, Egbert PR, Singh K, Haw WW, Blumenkranz MS, Ta CN.
`“Greater Elimination of Conjunctiva bacteria After Preoperative Irrigation with 10cc of 5%
`Povidone-Iodine.” The American Academy of Ophthalmology. Poster No. 166, October 2002.
`
`Chang RT, Ta CN, Egbert PR, Singh K, Haw WW, Shriver EM, Espinosa L, Williams DY,
`Blumenkranz MS, Miño de Kaspar H. “Bacterial Contamination of Paracentesis Blades Used in
`Cataract Surgery.” The Association for Research in Vision and Ophthalmology. Poster No. 363,
`May 2002.
`
`Shriver EM, Ta CN, Egbert PR, Singh K, Chang RT, Blumenkranz MS, Miño de Kaspar H.
`“Multiresistant Staphylococcus epidermidis on the Conjunctiva Prior to Intraocular Surgery.”
`The Association for Research in Vision and Ophthalmology. Poster No. 3074, May 2002.
`
`Glaconi Ja, Ta CN. “Comparing the Effect of Three Lid Specula on Intraocular Pressure.”
`Invest. Ophthalmol. Vis. Sci. 2001; 42(4):S26.
`
`
`
`12
`
`APOTEX 1008, pg. 12
`
`

`
`
`Ta CN, de Kaspar HM, Ebert P, Singh K, Blumenkranz M. “Antibiotic Susceptibility Pattern of
`Coagulase-Negative Staphylococci in patients Undergoing Intraocular Surgery.” Invest.
`Ophthalmol. Vis. Sci. 2001; 42(4):S254.
`
`Braun M, de Kaspar HM, Ta CN, Egbert P, Singh K, Blumenkranz M. “Immediate Bacterial
`Contamination of the Aqueous Humor in intraocular Surgery.” Invest. Ophthalmol. Vis. Sci.
`2001; 42(4):S256.
`
`Ta CN, McCulley JP, Shine WE, Pandya AG, Silvany R, Trattler W. “Effects of Minocycline on
`the Ocular Flora of Patients with Acne Rosacea and Seborrheic Blepharitis.” Invest.
`Ophthalmol. Vis. Sci. 1999; 40(4):S691.
`
`Ta CN, Manche EE. “Laser in-situ Keratomileusis for the Treatment of Low, Moderate, and
`High Myopia.” Invest. Ophthalmol. Vis. Sci. 1998; 39(4):S747.
`
`Luu JK, Ta CN, Singh K. “An Evaluation of Induced Postoperative Astigmatism Following
`Combined Trabeculectomy with Cataract Surgery.” Invest. Ophthalmol. Vis. Sci. 1998;
`39(4):S940.
`
`Ta C, Byrd S, Singh K. “The Effect of Transient Hypotony on Final Visual Acuity Following
`Combined Trabeculectomy with Cataract Surgery.” Invest. Ophthalmol. Vis. Sci. 1997; 38:S262.
`
`Byrd S, Ta CN, Singh K. “Medical Control of Intraocular Pressure Post Cataract Surgery: A
`Prospective Randomized Study.” Invest. Ophthalmol. Vis. Sci. 1997; 38:S546.
`
`Lin SA, David S, Ta CN, Singh K. “Progressive Visual Field Loss Following Mitomycin
`Trabeculectomy in Normotensive Patients.” Invest. Ophthalmol. Vis. Sci. 1996; 37:S28.
`
`
`
`SCIENTIFIC PRESENTATIONS
`
`Ta CN. “Chondro-ocular graft transfer: An alternative to allograft transplantation? ” The
`Association for Research in Vision and Ophthalmology. Seattle, Washington, May 7, 2013.
`Poster
`
`Ta CN. “Ocular Aspects of Bullous Disease.” 16th Annual International Pemphigus and
`Pemphigoid Foundation (IPPF) Patient Conference. San Francisco, CA, April 27, 2013.
`
`Ta CN. “Topical, Intracameral, and Intravitreal Ag